Son güncelleme :
19/11/2024
Antibiyotik   Ertapenem  
Enjeksiyon
Çözeltilerin stabilitesi Karışımlardaki stabilitesi Stabiliteyi etkileyen faktörler Uyumluluk Uygulama yöntemi Kaynaklar pdf
   Kimyasal yapı   

Ticari isim   Ticari isim     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Ertacrit Hindistan
Ertagram Peru
Ertamac Hindistan
Invanz Almanya, Amerika Birleşik Devletleri, Arjantin, Avustralya, Avusturya, Birleşik Arap Emirlikleri, Brezilya, Büyük Britanya, Danimarka, Ekvador, Fas, Finlandiya, Fransa, Hollanda, İrlanda, İspanya, İsveç, İsviçre, İtalya, İzlanda, Japonya, Kanada, Kolombiya, Lüksemburg, Macaristan, Malezya, Meksika, Mısır, Norveç, Peru, Polonya, Portekiz, Romanya, Şili, Türkiye, Venezuela, yeni Zelanda, Yunanistan
Lyortam Peru, Şili
Kaynaklar   Enjeksiyon    Kaynaklar : Ertapenem  
tip yayın
1906 Dergi McQuade MS, Van Nostrand V, Shariter J, Kanike JD, Forsyth RJ.
Stability and compatibility of reconstituted ertapenem with commonly used iv infusion and coinfusion solutions.
Am J Health-Syst Pharm 2004 ; 61: 38-45.
1912 Laboratuar Ertapenem (Invanz®) - Summary of Product Characteristics
Merck Sharp Dohme 2016
1982 Dergi Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2178 Dergi Zajac M, Cielecka-Piontek J, Jelinska A.
Stability of ertapenem in aqueous solutions.
J Pharm Biomed Anal 2007 ; 43: 445-449.
2247 Dergi Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
3208 Dergi Phipps Stephen D, Peacock Gina F, Smith Douglas L .
Stability of Ertapenem in an Elastomeric Infusion Device.
Int J Pharm Compound 2011 ; 15, 3: 252-254.
3254 Dergi Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3549 Laboratuar Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3674 Laboratuar Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
3717 Dergi Jain J.G, Sutherland C, Nicolau D.P, Kuti J.L.
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °C.
Am J Health-Syst Pharm 2014 ; 71:1480-1484
3824 Dergi Boudi S, Roy H, Forest JM, Leclair G.
Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y.
Pharmactuel 2023 2023;56,3:91-98
3827 afiş Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 afiş Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 afiş So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3891 Dergi Walker S.E, Law S, Perks W, Iazzetta J.
Stability of Ertapenem 100 mg/mL in Manufacturer’s Glass Vials or Syringes at 4°C and 23°C
Can J Hosp Pharm 2015 ; 68, 2: 121-126.
3997 Dergi Katip W.
Visual compatibility of colistin injection with other antibiotics during simulated Y-site administration.
Am J Health-Syst Pharm 2017 ; 74:14 : 1099-1102
4055 Dergi Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44
4145 Dergi Asempa T.E, Avery L.M, Kidd J.M, Kuti J.L, Nicolau D.P.
Physical compatibility of plazomicin with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 ;75,14:1048-1056
4319 Dergi Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G.
Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs.
Hosp Pharm 2020 ; 55, 5: 332-337.
4528 Dergi Lu J, Liu Q, Kupiec T, Vail H, Lunch L, Fam D, Vu N.
Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration.
Int J Pharm Compound 2021 ;25,1:52-61
4742 Dergi Macoviciuc M, Nguyen C, Forest J-M, Leclair G.
Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y.
Pharmactuel 2022 ; 55, 4: 247-255.
4801 Dergi Ruiz V, Yuwei Shen Y, Abouelhassan Y, Fouad A, Nicolau D, Kuti J.
Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2024 ;51,1:

  Mentions Légales